Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Retapamulin 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Sodium fusidate 20 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
tacalcitol 4 µg/g salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
salicylsyre 60 % i hvid blød paraffin 40 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
chlortetracyclinhydrochlorid 3 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Nystatin 100000 unit/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
gentamicinsulfat 0,1 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Nystatin 100 unit/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
erythromycin 2 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Bacitracin 500 unit/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Prednicarbate 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
miconazol 0,25 % + zinkoxid 15 % + hvid vaseline 81,35 % salve til topikal anvendelse |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
catechin 15 % salve til topikal anvendelse |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Dithranol 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
kamilleekstrakter 10,5 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betamethason 0,1 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betamethason 0,05 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Clobetasone butyrate 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Diflucortolone valerate 3 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
fluocortolon 0,5 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Mometasone furoate 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fluticasone propionate 50 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lithium succinate 80 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Povidone iodine 100 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Neomycin 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Cinchocaine 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betamethasondipropionat 0,5 mg/g salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fludroxycortide 250 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fludroxycortide 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Amcinonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Halcinonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Desoximetasone 2.5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone valerate 2 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Erythromycin 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betamethasondipropionat 0,5 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Aciclovir 50 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
lignocain 5 % + hydrocortisonacetat 0,275 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
tacrolimusmonohydrat 0,03 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
tacrolimusmonohydrat 0,1 % salve |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
lidocain 2,5 % salve til topikal anvendelse |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Tetracycline 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely betamethasone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Crisaborole 20 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Tirbanibulin 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely tacalcitol 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lysine hydrochloride 150 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|